Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

JJanux Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
J

Janux Therapeutics, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $10.27M. Net result −$21.97M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $10.27M. Running result $10.27M. Revenue: $10.27M.
  • Cost of revenue: $0. Running result $10.27M.
  • Gross profit: $10.27M. Running result $10.27M.
  • Research and development: −$30.99M. Running result −$20.73M.
  • General and administrative: −$10.96M. Running result −$31.69M.
  • Operating income: −$31.69M. Running result −$31.69M.
  • Other income: $9.72M. Running result −$21.97M.
  • Pre-tax loss: −$21.97M. Running result −$21.97M.
  • Income tax benefit: $0. Running result −$21.97M.
  • Net loss: −$21.97M. Running result −$21.97M.